LJPC Financial Statements From 2010 to 2024
| LJPCDelisted Stock | USD 6.22 0.00 0.00% |
Check La Jolla financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LJPC main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . LJPC financial statements analysis is a perfect complement when working with La Jolla Valuation or Volatility modules.
LJPC |
La Jolla Pharmaceutical Company Return On Asset Analysis
La Jolla's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current La Jolla Return On Asset | 1.64 |
Most of La Jolla's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, La Jolla Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, La Jolla Pharmaceutical has a Return On Asset of 1.64. This is 118.74% lower than that of the Healthcare sector and 106.95% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably lower than that of the firm.
La Jolla Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining La Jolla's current stock value. Our valuation model uses many indicators to compare La Jolla value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across La Jolla competition to find correlations between indicators driving La Jolla's intrinsic value. More Info.La Jolla Pharmaceutical is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies reporting about 30.15 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value La Jolla by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for La Jolla's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the La Jolla's earnings, one of the primary drivers of an investment's value.About La Jolla Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include La Jolla income statement, its balance sheet, and the statement of cash flows. La Jolla investors use historical funamental indicators, such as La Jolla's revenue or net income, to determine how well the company is positioned to perform in the future. Although La Jolla investors may use each financial statement separately, they are all related. The changes in La Jolla's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on La Jolla's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on La Jolla Financial Statements. Understanding these patterns can help to make the right decision on long term investment in La Jolla. Please read more on our technical analysis and fundamental analysis pages.
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. La Jolla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in LJPC Stock
If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |